Nutraceutical Therapy Seminar
A FUNCTIONAL AND INTEGRATIVE APPROACH
Nutraceutical therapy has been shown to contribute significantly to an individual’s overall health. Indeed, the use of nutraceuticals has been associated with positive outcomes across nearly all physiological systems, including immunology, neurology, mental health, orthopaedics, cosmetics, obstetrics, cancer and other pathologies, among much more. With advances in molecular biology and genetics, nutrient and health relations are beginning to be teased apart. Over the past few decades, an abundance of scientific data has emerged highlighting the important and essential role nutrients play in cellular and epigenetic signalling. Understanding the mechanisms of nutrient actions will allow healthcare providers to better assess nutrient deficiencies and appropriately target nutraceutical interventions.
In this live event course, participants will gain a comprehensive understanding of nutrient signalling with particular emphasis on nutrient roles in methylation and epigenetic processes. Connections between methylation pathways, nutrient involvement, and the presence/absence of pathology will be made. After acquiring a foundational knowledge on nutrient molecular mechanisms, participants will assess detailed patient data, including prior medical history, familial history, differential diagnoses, lifestyle behaviours, signs and symptoms, biological assays, among much more. Participants will be encouraged to take a functional and integrative approach towards nutraceutical medicine that involves addressing the underlying cause of disease. In doing so, participants will learn about the need for customised nutraceutical therapeutics.
This program will allow pharmacists and healthcare providers with the unique opportunity to collaborate to produce patient-centred treatment regimens tailored to the individual. In attending the program, participants will leave with the confidence and knowledge required for effective and optimal nutraceutical medicine.
Physicians, pharmacists and healthcare providers engaged in nutraceutical treatment options for methylation disorders.
A live event with case studies and competency assessments.
- Recognise and understand regulations surrounding nutraceutical therapy.
- Understand the bases and technologies which are appropriate when compounding nutraceutical medications.
- Develop a comprehensive understanding of epigenetic and methylation processes.
- Evaluate scientific data and findings on the relation between aberrant methylation and common pathologies.
- Recognise the important and necessary role of nutrients in methylation pathways.
- Identify the individualised nature of nutrient and methylation profiles and the need for personalised nutraceutical therapy.
- Examine and develop an understanding of treatment options for methylation disorders including Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Anxiety, Depression and Heavy Metal Toxicity.
- Analyse comprehensive patient cases, including prior medical history, familial history, differential diagnoses, lifestyle behaviours, signs and symptoms, laboratory test results, current and past pharmacotherapeutic and supplementation treatments.
- Develop alternative and customised therapeutic regimens tailored to patient-specific needs.
Lily Tomas, MD, MBBS (UNSW), RACGP
Dr. Lily Thomas is an Integrative Medical Doctor practicing on the Sapphire Coast in NSW, Australia with over 20 years’ experience in treating all aspects of Health. Dr. Thomas is a Fellow of the Australasian College of Nutrition and Environmental Medicine (ACNEM) and Past President of the Australian Integrative Medical Association (AIMA). Dr. Tomas was the founding Editor of Advances in Integrative Medicine, Elsevier. Dr. Thomas has also had the pleasure of lecturing at many renowned organizations and associations, including AIMA, ACNEM, Australasian Academy of Anti-Aging Medicine (A5M), Australian Lifestyle Medicine Association (ALMA), BioBalance Health Australia, MINDD Foundation, Australian Acupuncture & Chinese Medicine Association (AACMA), University of Western Sydney- Medicine Faculty, Royal Australian College of General Practitioners (RACGP), and the McGrath Foundation- Breast Cancer.
Patricia Ullmann, B.Pharm
Patricia Ullmann is a registered pharmacist with broad experience in community pharmacy and in compounding pharmacy since the 1990s. She has spent 15 years as pharmacist-in-charge at one of Australia’s most successful and pioneering compounding pharmacies. Her experience includes the implementation of laboratory standard operating procedures; regulatory compliance; brand promotion and marketing strategies; patient counselling; collaboration with physicians and other health care professionals; and people policies/practices.
Patricia has been a member of the TGA’s Pharmacy Manufacturing Technical Working Group. She has contributed to reviews of compounding in Professional Practice Standards and in Australian Pharmaceutical Formulary and Handbook (PSA). She has been published in articles of the Australian Journal of Pharmacy and is currently a Joint Chair of the Australian Society of Compounding Pharmacists.
Since 2012, Patricia has been the CPD coordinator/editor and compounding pharmacist at Medisca Australia, where she is the Manager of Training and Technical Services
Mr. Shirt is a Business Development Executive at MEDISCA Australia specializing in providing pharmacists and pharmacy owners with the tools they need to expand and create awareness about their compounding practice. Prior to his current role, Mr. Shirt gained valuable skills in pharmaceutical compounding sales and business strategies as an Account Executive at MEDISCA Australia. Throughout the years, Mr. Shirt has worked closely with a number of community pharmacies throughout the New South Wales and Australian Capital Territory and has personally participated in the growth and development of their compounding practice.
*The facilitator for the CPD accredited activity is Dr Lily Tomas. Patricia Ullmann and Daniel Shirt facilitate the non-accredited additional training on the second day, which is designed for pharmacists and pharmacy technicians.
This activity has been accredited for 8.0 hours of Group One CPD (or 8.0 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 8.0 hours of Group Two CPD (or 16.0 CPD credits) upon successful completion of relevant assessment activities. The activity A1905MED1 accreditation expires 6 May 2021.
Activity material is Copyright© 2018-2019 LP3 Network Inc.
Full attendance and the completion of an activity evaluation and practical skill set competency evaluation are a compulsory requirement to achieve a certificate of attendance for the live event.
DECLARATIONS AND DISCLOSURES
It is a requirement that full disclosure of conflicts of interest be made available to participants. This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the activity participant.
FOOD AND BEVERAGE
As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.
CANCELLATION AND REFUND POLICY
In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.
TRANSFER POLICY – AUSTRALIA COURSES ONLY
This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.
An additional Nutraceuticals training day for pharmacists and pharmacy technicians follows this training. The additional day is not accredited for CPD credits.